Spyre Therapeutics
SYRE
#4930
Rank
HK$10.88 B
Marketcap
HK$185.39
Share price
3.16%
Change (1 day)
30.65%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -HK$1.53 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$1 Billion a decrease over its 2022 earnings that were of -HK$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.53 Billion52.38%
2023 -HK$1 Billion51.64%
2022 -HK$0.66 Billion29.14%
2021 -HK$0.52 Billion-19.43%
2020 -HK$0.64 Billion1.43%
2019 -HK$0.63 Billion76.7%
2018 -HK$0.36 Billion64.27%
2017 -HK$0.22 Billion26.34%
2016 -HK$0.18 Billion93.6%
2015 -HK$87.92 Million27.08%
2014 -HK$69.19 Million